This Article Full Text Full Text (PDF) Supplementary Data Correction (v69,p7130) All Versions of this Article: 0008-5472.CAN-08-2725v1 69/5/1800    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Endo-Munoz, L. Articles by Saunders, N. Search for Related Content PubMed PubMed Citation Articles by Endo-Munoz, L. Articles by Saunders, N.

E2F7 Can Regulate Proliferation, Differentiation, and Apoptotic Responses in Human Keratinocytes: Implications for Cutaneous Squamous Cell Carcinoma Formation

¹ Translational Research Unit, Cancer Collaborative Group, Princess Alexandra Hospital; ² Epithelial Pathobiology Group, Cancer Biology Programme, Diamantina Institute for Cancer, Immunology and Metabolic Medicine and ³ Department of Surgery, University of Queensland, Princess Alexandra Hospital, Wooloongabba, Queensland, Australia and ⁴ Epithelial Stem Cell Laboratory, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia

Requests for reprints: Nicholas Saunders, Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Wooloongabba, Queensland 4102, Australia. Phone: 61-7-3240-5894; Fax: 61-7-3240-5946; E-mail: nsaunders{at}uq.edu.au.

Key Words: Squamous differentiation • keratinocytes • E2F7 • differentiation • proliferation

The E2F family of transcription factors plays a crucial role in the regulation of genes involved in cell proliferation, differentiation, and apoptosis. In keratinocytes, the inhibition of E2F is a key step in the control and initiation of squamous differentiation. Because the product of the recently identified E2F7a/E2F7b gene has been shown to repress E2F-regulated promoters, and to be abundant in skin, we examined its role in the epidermis. Our results indicate that E2F7b mRNA expression is selectively associated with proliferation-competent keratinocytes. Moreover, E2F7 was able to antagonize E2F1-induced proliferation and apoptosis. In contrast, although E2F7 was able to inhibit proliferation and initiate differentiation, it was unable to antagonize the differentiation suppression induced by E2F1. These data indicate that E2F7-mediated suppression of proliferation and apoptosis acts through E2F1-dependent pathways, whereas E2F7-induced differentiation acts through an E2F1-independent pathway. These data also suggest that proliferation, differentiation, and survival of primary human keratinocytes can be controlled by the relative ratio of E2F1 to E2F7. Because deregulated proliferation, differentiation, and apoptosis are hallmarks of cancer, we examined the expression levels of E2F1 and E2F7 in cutaneous squamous cell carcinomas (CSCC). We found that both genes were overexpressed in CSCCs compared with normal epidermis. Furthermore, inhibition of E2F7 in a SCC cell line sensitized the cells to UV-induced apoptosis and doxorubicin-induced apoptosis. Combined, these data suggest that the selected disruption of E2F1 and E2F7 in keratinocytes is likely to contribute to CSCC formation and may prove to be a viable therapeutic target. [Cancer Res 2009;69(5):1800–9]

This article has been cited by other articles:

				Correction: Article on E2F7 in SCC Cancer Res., September 1, 2009; 69(17): 7130 - 7130. [Full Text] [PDF]